Clinical Evidence

Delve into clinical research studies and more 

Clinical research lies at the heart of who we are. Vantive uses scientific evidence systematically and transparently, to inform the development of state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Vantive.

254 results

HDx therapy enabled by Theranova
Targeting proinflammatory cytokines ameliorates calcifying phenotype conversion of vascular progenitors under uremic conditions in vitro
Visit resource site
PD
Temporal evolution in the selection of apd cycler-embedded remote patient management flag alerts by health care practitioners (HCPs): lessons to accelerate the RPM learning curve? - Firanek C et al.
Visit resource site
HDx therapy enabled by Theranova
The Budgetary Impact of Introducing HDx therapy enabled by Theranova Dialyzer compared to High Flux Hemodialysis in private sector in the Kingdom of Saudia Arabia
Visit resource site
HDx therapy enabled by Theranova
The Comparison of Vancomycin Removal Between Medium Cut-Off (Theranova®) and Other Dialyzers
Visit resource site
HDx therapy enabled by Theranova
The Efficacy of Post-Dilution Online Hemodiafiltration and Medium Cut-Off Dialyser on the Removal of Protein-Bound Uremic Toxins
Visit resource site
HDx therapy enabled by Theranova
The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease
Visit resource site
PD
The impact of a remote monitoring system of healthcare resource consumption in patients on automated peritoneal dialysis (APD): A simulation study - Uchiyama et al.
Visit resource site
PD
The Impact of Automated Peritoneal Dialysis (APD) with Remote Patient Management (RPM): Changing the Nursing Paradigm to Proactive Clinical Management - Firanek CA, et al.
Download
HDx therapy enabled by Theranova
The Medium Cut-Off Membrane Does Not Lower Protein-Bound Uremic Toxins
Visit resource site
HDx therapy enabled by Theranova
The optimized anticoagulation strategy in prolonged hemodialysis.
Visit resource site
HDx therapy enabled by Theranova
The Place of Large Pore Membranes in the Treatment Portfolio of Patients on Hemodialysis
Visit resource site
HDx therapy enabled by Theranova
The Proteome of Hemodialysis Membranes: A Discovery Proteomic Pilot Study
Visit resource site

Vantive is a trademark of Vantive Health LLC or its affiliates.